Kyverna Therapeutics, Inc. (KYTX)
8.24
-0.18
(-2.14%)
USD |
NASDAQ |
Aug 24, 16:00
8.23
-0.01
(-0.12%)
After-Hours: 20:00
Kyverna Therapeutics 1 Year Total Returns (Daily) : 114.0% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 114.0% |
| August 21, 2026 | 135.2% |
| August 20, 2026 | 137.0% |
| August 19, 2026 | 168.8% |
| August 18, 2026 | 140.1% |
| August 17, 2026 | 155.0% |
| August 14, 2026 | 130.8% |
| August 13, 2026 | 132.9% |
| August 12, 2026 | 166.6% |
| August 11, 2026 | 158.7% |
| August 10, 2026 | 143.5% |
| August 07, 2026 | 140.5% |
| August 06, 2026 | 132.7% |
| August 05, 2026 | 124.0% |
| August 04, 2026 | 130.9% |
| August 03, 2026 | 118.3% |
| July 31, 2026 | 104.5% |
| July 30, 2026 | 99.20% |
| July 29, 2026 | 83.64% |
| July 28, 2026 | 72.98% |
| July 27, 2026 | 82.91% |
| July 24, 2026 | 74.76% |
| July 23, 2026 | 68.36% |
| July 22, 2026 | 80.49% |
| July 21, 2026 | 93.28% |
| Date | Value |
|---|---|
| July 20, 2026 | 85.64% |
| July 17, 2026 | 83.05% |
| July 16, 2026 | 82.80% |
| July 15, 2026 | 103.7% |
| July 14, 2026 | 80.66% |
| July 13, 2026 | 92.80% |
| July 10, 2026 | 137.7% |
| July 09, 2026 | 215.4% |
| July 08, 2026 | 251.4% |
| July 07, 2026 | 279.6% |
| July 06, 2026 | 226.0% |
| July 02, 2026 | 214.7% |
| July 01, 2026 | 204.7% |
| June 30, 2026 | 190.2% |
| June 29, 2026 | 167.7% |
| June 26, 2026 | 143.2% |
| June 25, 2026 | 167.1% |
| June 24, 2026 | 170.2% |
| June 23, 2026 | 161.8% |
| June 22, 2026 | 170.4% |
| June 18, 2026 | 177.3% |
| June 17, 2026 | 171.6% |
| June 16, 2026 | 151.4% |
| June 15, 2026 | 153.1% |
| June 12, 2026 | 132.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cartesian Therapeutics, Inc. | -10.42% |
| Allogene Therapeutics, Inc. | 70.59% |
| Beam Therapeutics, Inc. | 70.25% |
| Arrowhead Pharmaceuticals, Inc. | 306.6% |
| Oncolytics Biotech, Inc. | -16.43% |